Hematopoietic Stem Cell Transplantation
📧 Sign up to get email alerts when something new happens for Hematopoietic Stem Cell Transplantation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-15Clinical Trial Update: AntiCMV molécules Monitoring in Real-life in Stem Cell Recipients
A completed clinical trial evaluating real-world monitoring of anti-CMV therapies in hematopoietic stem cell transplant recipients.
-
CLINICAL_TRIALS trial_result · 2024-11-18Clinical Trial Update: Benefits of Intrahospital Exercise Program in Pediatric HSCT [NA]
A completed trial evaluated an intrahospital exercise program for pediatric patients undergoing hematopoietic stem cell transplantation and …
-
CLINICAL_TRIALS trial_result · 2023-10-06Clinical Trial Update: Low Power Laser Therapy As Prevention Of Oral Mucositis And Oropharyngeal Pain In Patients Undergoing Allogenetic HSCT [Phase 3]
A Phase 3 trial evaluating low power laser (low-level light therapy) as prevention of oral mucositis and oropharyngeal pain in patients unde…
-
CLINICAL_TRIALS trial_result · 2023-09-15Clinical Trial Update: Gut Decontamination In Pediatric Allogeneic Hematopoietic [Phase 2]
Phase 2 trial update on gut decontamination in pediatric allogeneic hematopoietic stem cell transplantation with data posted after completio…
-
CLINICAL_TRIALS trial_result · 2023-09-01Clinical Trial Update: Letermovir for the Prevention of CMV Infection in HSCT Recipients Based on the Outcome of mNGS [Phase 2]
Phase 2 clinical trial updating the use of letermovir for prevention of CMV infection in hematopoietic stem cell transplant recipients, eval…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-03-09Clinical Trial Update: A Study of Tacrolimus/Methotrexate and Tocilizumab to Prevent Acute Graft-Versus-Host Disease (AGVD) After Allogeneic Hematopoietic Stem Cell Transplant [Phase 2]
Phase 2 trial evaluating tacrolimus/methotrexate with tocilizumab to prevent acute graft-versus-host disease after allogeneic hematopoietic …
-
CLINICAL_TRIALS trial_result · 2023-02-15Clinical Trial Update: Clinical Study of rATG Individualized Administration in Haploidentical Hematopoietic Stem Cell Transplantation [Phase 4]
Phase 4 clinical study evaluating individualized administration of anti-thymocyte globulin (rATG) in haploidentical hematopoietic stem cell …
-
CLINICAL_TRIALS trial_result · 2022-11-14Clinical Trial Update: Efprezimod Alfa (CD24Fc, MK-7110) for the Prevention of Acute Graft Versus Host Disease (GVHD) Following Myeloablative Hematopoietic Stem Cell Transplantation (HSCT) (MK-7110-005) [Phase 3]
Phase 3 trial evaluating Efprezimod Alfa (CD24Fc, MK-7110) for prevention of acute graft-versus-host disease after myeloablative HSCT; study…
-
CLINICAL_TRIALS trial_result · 2022-05-17Clinical Trial Update: Maraviroc in Patients Undergoing Non-Myeloablative Allogeneic Stem-Cell Transplantation [Phase 1, Phase 2]
Clinical trial updates on maraviroc for patients undergoing non-myeloablative allogeneic stem-cell transplantation (Phase 1/Phase 2).
-
CLINICAL_TRIALS trial_result · 2022-05-09Clinical Trial Update: Effectiveness of COVID-19 Vaccine in Hematopoietic Stem Cell Transplant Patients [Phase 2]
Phase 2 trial evaluating the effectiveness of a COVID-19 vaccine in patients who have undergone hematopoietic stem cell transplantation.
-
CLINICAL_TRIALS trial_result · 2021-06-18Clinical Trial Update: Phase II Trial of Efprezimod Alfa (CD24Fc, MK-7110) for the Prevention of Acute Graft-Versus-Host Disease (GVHD) Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) (MK-7110-002) [Phase 2]
Phase II trial update on Efprezimod Alfa (CD24Fc, MK-7110) for prevention of acute GVHD after myeloablative allogeneic HSCT; trial completed…
-
CLINICAL_TRIALS trial_result · 2021-04-26Clinical Trial Update: High Dose Intravenous Thiamine for the Prevention of Delirium in Allogeneic Hematopoietic Stem Cell Transplantation [Phase 2]
Phase 2 trial evaluating high-dose intravenous thiamine to prevent delirium in patients undergoing allogeneic hematopoietic stem cell transp…
-
CLINICAL_TRIALS trial_result · 2021-03-09Clinical Trial Update: Efficacy of N-acetylcysteine Versus Placebo as Prophylaxis of Sinusoidal Obstruction Syndrome in Patients Undergoing Hematopoietic Stem Cell Transplantation [Phase 2]
Phase 2 clinical trial evaluating N-acetylcysteine versus placebo for prevention of Sinusoidal Obstruction Syndrome in patients undergoing h…
-
CLINICAL_TRIALS trial_result · 2021-02-26Clinical Trial Update: TCR Alpha/Beta Depletion for HSCT From Haploidentical and Unrelated Donors in the Treatment of PID [Phase 2, Phase 3]
Phase 2/3 trial evaluating TCR alpha/beta depletion for hematopoietic stem cell transplantation from haploidentical and unrelated donors in …
-
CLINICAL_TRIALS trial_result · 2020-12-29Clinical Trial Update: Sitagliptin for Prevention of Acute Graft Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation [Phase 2]
Phase 2 trial evaluating sitagliptin for prevention of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantat…
-
CLINICAL_TRIALS trial_result · 2020-12-01Clinical Trial Update: Fecal Microbiome Transplantation (FMT) in Pediatric Patients Colonized With Antibiotic-resistant Pathogens Before Hematopoietic Stem Cell Transplantation (HSCT) [Phase 2]
Phase 2 clinical trial investigating fecal microbiome transplantation in pediatric patients colonized with antibiotic-resistant pathogens pr…
-
CLINICAL_TRIALS trial_result · 2020-09-17Clinical Trial Update: Post-transplantation Cyclophosphamide for Haploidentical Transplant From Maternal or Collateral Donors [Phase 4]
Phase 4 trial update evaluating post-transplant cyclophosphamide for haploidentical hematopoietic stem cell transplantation.
-
CLINICAL_TRIALS trial_result · 2019-12-17Clinical Trial Update: Problem-Solving Education for Caregivers and Patients During Stem Cell Transplant [Phase 2]
Phase 2 clinical trial evaluating problem-solving education for caregivers and patients during hematopoietic stem cell transplantation has c…
-
CLINICAL_TRIALS trial_result · 2019-12-06Clinical Trial Update: Recombinant Human Thrombopoietin for Mobilization of Peripheral Blood Progenitor Cells for Autologous Transplantation [Phase 1, Phase 2]
A clinical trial update describes the investigation of recombinant human thrombopoietin for mobilizing peripheral blood progenitor cells in …
-
CLINICAL_TRIALS trial_result · 2019-08-26Clinical Trial Update: Sorafenib for Prophylaxis of Leukemia Relapse in Allo-HSCT Recipients With FLT3-ITD Positive AML [Phase 2, Phase 3]
Clinical trial evaluating sorafenib to prevent leukemia relapse after allogeneic stem cell transplantation in FLT3-ITD positive AML; complet…
-
CLINICAL_TRIALS trial_result · 2018-12-12Clinical Trial Update: A Trial of Plerixafor/G-CSF as Additional Agents for Conditioning Before TCR Alpha/Beta Depleted HSCT in WAS Patients [Phase 2]
Phase 2 trial evaluating plerixafor/G-CSF as conditioning agents before TCR alpha/beta depleted HSCT in patients with Wiskott-Aldrich Syndro…
-
CLINICAL_TRIALS trial_result · 2018-08-31Clinical Trial Update: Ledipasvir/Sofosbuvir Treatment for Hepatitis C in HCT Recipients. [Phase 4]
Phase 4 trial update for ledipasvir/sofosbuvir in hematopoietic stem cell transplant recipients has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-10-05Clinical Trial Update: Intrabone Infusion of Umbilical Cord Blood Stem Cells [Phase 2]
Phase 2 clinical trial update on intrabone infusion of umbilical cord blood stem cells for hematopoietic stem cell transplantation.
-
CLINICAL_TRIALS trial_result · 2014-06-26Clinical Trial Update: NOX-A12 Multiple Ascending Dose Study in Healthy Volunteers [Phase 1]
A Phase 1 multiple ascending dose trial of NOX-A12 in healthy volunteers has completed, in the context of hematopoietic stem cell transplant…
-
CLINICAL_TRIALS trial_result · 2012-03-23Clinical Trial Update: Dose Escalation Study Of Palifermin in Pediatric Research Participants Undergoing Allogeneic Hematopoietic Stem Cell Transplantation [Phase 1]
This update notes the completion of a Phase 1 dose-escalation trial of palifermin in pediatric participants undergoing allogeneic hematopoie…